Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Exchange: New York
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Generic Pharma

Taro Pharmaceutical Industries Ltd

+ Add to Watchlist

TARO:US

143.2200 USD 1.2200 0.86%

As of 20:04:02 ET on 03/27/2015.

Snapshot for Taro Pharmaceutical Industries Ltd (TARO)

Open: 142.2500 Day's Range: 141.9400 - 144.3399 Volume: 26,282
Previous Close: 142.0000 52wk Range: 102.7200 - 173.0000 1-Yr Rtn: +30.37%

Stock Chart for TARO

No chart data available.
  • TARO:US 143.2200
  • 1D
  • 1M
  • 1Y
142.0000
Interactive TARO Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for TARO

Current P/E Ratio (ttm) 14.6212
Estimated P/E(03/2015) 13.4859
Relative P/E vs. SPX -
Earnings Per Share (USD) (ttm) 9.7954
Est. EPS (USD) (03/2015) 10.6200
Est. PEG Ratio -
Market Cap (M USD) 6,133.97
Shares Outstanding (M) 42.83
30 Day Average Volume 75,063
Price/Book (mrq) 4.6583
Price/Sale (ttm) 7.6116
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 05/27/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for TARO

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for TARO

Taro Pharmaceutical Industries Ltd. is a multinational, science-based pharmaceutical company that discovers, develops, manufactures, and markets healthcare products. The Company's products include prescription and over-the-counter drugs.

Kalyanasundaram Subramanian "Kal"Chief Executive OfficerMichael Perfetto Chief Commercial Officer
Avi AvramoffGlobal VP:Research & DevMichael H KalbVP/Interim CFO/Chief Acctg Ofcr
More Company Profile & Key Executives for TARO

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil